Vaxzevria and mRNA COVID-19 vaccines showed similar and favourable safety profiles in a population-based cohort study of over a million people
- Details
- Category: AstraZeneca

Pfizer and BioNTech to provide U.S. government with an additional 200 million doses of COVID-19 vaccine
- Details
- Category: Pfizer

AstraZeneca and Regeneron to research, develop and commercialise new small molecule medicines for obesity
- Details
- Category: AstraZeneca

Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate COVID-19
- Details
- Category: Roche

Pfizer and BioNTech announce collaboration with Biovac to manufacture and distribute COVID-19 vaccine doses within Africa
- Details
- Category: Pfizer

U.S. FDA grants Priority Review for the Biologics License Application for Pfizer-BioNTech COVID-19 vaccine
- Details
- Category: Business

Collaboration between AbbVie, Biogen and Pfizer creates world's largest browsable resource linking rare protein-coding genetic variants to human health and disease
- Details
- Category: Pfizer

More Pharma News ...
- Tezepelumab granted Priority Review by U.S. FDA
- Positive new data for Johnson & Johnson single-shot COVID-19 vaccine on activity against Delta variant and long-lasting durability of response
- GSK and Alector announce global collaboration in immuno-neurology
- Moderna announces emergency use authorization for its COVID-19 vaccine granted by government of India
- Sanofi launches dedicated vaccines mRNA Center of Excellence
- Roche's Actemra/RoActemra receives U.S. FDA Emergency Use Authorization for the treatment of COVID-19 in hospitalised adults and children
- Novartis and Hewlett Packard Enterprise join forces to advance Novartis global health efforts